Skip to content
Translational Neuropharmacology Lab (Zanos Lab)

Translational Neuropharmacology Lab (Zanos Lab)

Our laboratory, based in Cyprus, employs molecular and systems neuroscience, behavioral pharmacology, as well as advanced computational methods to unravel the mysteries of brain diseases and identify targets for the development of novel and effective pharmacotherapies.

Menu
  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Category: News

News

Dr. Zanos meets Prof. George Paxinos at the Mediterranean Neuroscience Society 2025 conference

No Comments
| News

We’re excited to share a special moment from the 10th Mediterranean Neuroscience Society Conference 2025 in Crete, Greece. Our lab director had the incredible opportunity to meet Professor George Paxinos AO, one of the most influential figures in modern neuroscience. Professor Paxinos is universally recognized as “the man who mapped the brain.” He’s the author […]

Read More »

Dr. Zanos chairs ketamine research symposium at the Mediterranean Neuroscience Society conference 2025

No Comments
| News

Dr. Panos Zanos represented our lab at the Mediterranean Neuroscience Society Conference in Crete, where he chaired a symposium on ketamine’s rapid antidepressant mechanisms. The symposium, titled “Unraveling ketamine’s rapid antidepressant mechanisms: From neural circuits to clinical implications,” brought together leading researchers from around the world to discuss cutting-edge findings on how ketamine works as […]

Read More »

Dr. Michael presents new research on the potential efficacy of ketamine’s metabolite hydroxynorketamine for opioid addiction

No Comments
| News

Dr. Michael (Marie Curie fellow from our lab) presented new research at the Mediterranean Neuroscience Society Conference in Crete, showcasing our latest findings on how a ketamine metabolite could help treat opioid addiction. Her poster focused on (2R,6R)-hydroxynorketamine (HNK), a ketamine metabolite, and its effects on opioid addiction-related behaviors in mice. The research tackled one […]

Read More »

Dr. Zanos discusses social media’s impact on the brain at Pan-Cypriot Festival of Youth and Students event

No Comments
| News

Dr. Panos Zanos delivered an engaging discussion on “Social Media & Brain” as part of the 37th Pan-Cypriot Festival of Youth and Students. The talk explored the fascinating intersection between our digital habits and neurological processes, including insights from current research on how social media platforms influence brain function, potentially covering topics such as dopamine reward […]

Read More »

Dr. Polymnia Louka’s inspiring talk at the European University Cyprus annual conference

No Comments
| News

The Zanos Lab is delighted to share that Dr. Polymnia Louka, our Marie Skłodowska-Curie Fellow, delivered an engaging talk at the European University Cyprus (EUC) Annual Conference. Invited to address students and faculty, Dr. Louka discussed her journey to securing the prestigious and competitive Marie Curie Fellowship, as well as her innovative research exploring the […]

Read More »

Zanos Lab part of the newly-awarded European COST action “PSY-NET” (Psychedelic renaissance)

No Comments
| News

We are pleased to announce that the Zanos Lab at the University of Cyprus is an integral part of the newly awarded COST Action “PSY-NET: Psychedelic renaissance: turn on, tune in and drop in” (OC-2024-1-27517). This collaborative network brings together 83 leading researchers from 21 European countries to advance psychedelic research across multiple disciplines. The […]

Read More »

Zanos Lab research on biomarkers of nicotine addiction relapse presented at the Hellenic Psychological Society conference

No Comments
| News

The Zanos Lab is pleased to announce that Dr. Apostolakis has presented research at the Hellenic Psychological Society (ΕΛΨΕ) conference in Ioannina, Greece. The presentation, titled “Stress biomarkers and emotion regulation difficulties as predictive factors of vulnerability to nicotine addiction relapse,” addressed a critical challenge in smoking cessation efforts. Nicotine addiction is characterized by high […]

Read More »

Dr. Zanos presented groundbreaking ketamine research at University of Bern’s Neuroscience lecture series

No Comments
| News

We are pleased to announce that Dr. Panos Zanos, Director of the Zanos Lab at the University of Cyprus, recently delivered a lecture as part of the prestigious Neuroscience Lecture Series (NLS) at the University of Bern, Switzerland, for the 2024/25 academic year. Dr. Zanos presented the lab’s cutting-edge research on ketamine’s antidepressant properties, challenging […]

Read More »

Zanos Lab research decodes molecular pathways in Opioid Use Disorder and Depression at Hellenic Psychological Society conference

No Comments
| News

Dr. Zanos has presented new research of our lab at the Hellenic Psychological Society (ΕΛΨΕ) conference in Ioannina, Greece. The presentation, titled “Decoding common molecular pathways affected in opioid use disorder and depression,” explored the complex relationship between these frequently co-occurring conditions. This research was led by our lab members, Drs. Anna Onisiforou and Andrea […]

Read More »

Our postdoctoral fellow, Dr. Andria Michael, presents at YUFE4Postdocs workshop in University of Antwerp

No Comments
| News

We are pleased to announce that our postdoctoral researcher, Dr. Andria Michael, recently participated in the YUFE4Postdocs training workshop hosted at the University of Antwerp. The workshop focused on stakeholder interaction and open science practices, bringing together talented postdoctoral researchers from across the YUFE alliance. During this spring workshop, Dr. Michael had the opportunity to […]

Read More »

Posts pagination

Previous 1 … 4 5 6 … 13 Next

Recent Posts

  • Dr. Charalambous presents brain aging research at AAIC 2026 July 13, 2026
  • Dr. Panoutsopoulos presents research on ketamine and early neurodevelopment at FENS Forum 2026 July 8, 2026
  • Research spotlight: Unraveling the role of Eukaryotic Elongation Factor 2 Kinase in the antidepressant mechanism of (2R,6R)-hydroxynorketamine June 4, 2026
  • Research spotlight: Alexithymia and emotion regulation across smoking status groups May 26, 2026
  • New manuscript: The Immunosuppression Paradox in Multiple Sclerosis: Are We Fueling the Fire by Suppressing Immunity in an Epstein–Barr Virus–Linked Disease? March 12, 2026

Navigation

  • Home
  • News
  • Team Members
    • Lab Director
    • Current Team Members
    • Alumni
  • Research
  • Research Units
    • Translational Neuropharmacology Unit
    • Clinical Neuropsychopharmacology Unit
    • AI & Systems Bioinformatics Unit Cyprus
    • Genetic Epidemiology Unit
  • Facilities
  • Publications
  • Media
  • Join Us
  • Contact
  • More

Translational Neuropharmacology Lab (Zanos Lab) 2026 . Powered by WordPress